A systematic review of limiting antigen avidity enzyme immunoassay for detection of recent HIV-1 infection to expand supported applications
Author:
Funder
Janssen Pharmaceuticals
ViiV Healthcare
Merck
Gilead Sciences
Publisher
Elsevier BV
Subject
Virology,Infectious Diseases,Public Health, Environmental and Occupational Health,Immunology,Epidemiology
Reference53 articles.
1. Understanding Fast-Track; Accelerating Action to End the AIDS Epidemic by 2030,2021
2. UNAIDS Fact Sheet - World AIDS Day 2021,2021
3. Viral load criteria and threshold optimization to improve HIV incidence assay characteristics;Kassanjee;AIDS,2016
4. Moving towards a reliable HIV incidence test – current status, resources available, future directions and challenges ahead;Murphy;Epidemiol Infect,2017
5. Detection of recent HIV-1 infection using a new limiting-antigen avidity assay: potential for HIV-1 incidence estimates and avidity maturation studies;Duong;PLoS One,2012
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Response to Waja and Motlogeloa (2024): The need for robust research methodology when studying climate and health in developing countries;South African Journal of Science;2024-07-31
2. HIV acute infection and long-term undisclosed HIV status among blood donors from the highly endemic Amazonas state, located in the Brazilian Amazon;The Brazilian Journal of Infectious Diseases;2024-07
3. Sustained high HIV incidence among men who have sex with men in Jiangsu province, China: based on the limiting-antigen avidity EIA method and six consecutive surveys, 2016–2021;Frontiers in Public Health;2023-11-20
4. Rapid and visual identification of HIV-1 using reverse transcription loop-mediated isothermal amplification integrated with a gold nanoparticle-based lateral flow assay platform;Frontiers in Microbiology;2023-07-12
5. Facilitating Next‐Generation Pre‐Exposure Prophylaxis Clinical Trials UsingHIVRecent Infection Assays: A Consensus Statement from the ForumHIVPrevention Trial Design Project;Clinical Pharmacology & Therapeutics;2023-01-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3